PALO ALTO, Calif.--(BUSINESS WIRE)--March 16, 2006--StemCells, Inc. (NASDAQ: STEM) today reported its financial results for the fourth quarter and the year ended December 31, 2005. The Company reported a net loss of $4,328,000, or $0.07 per share, for the fourth quarter ended December 31, 2005, compared to a net loss of $4,919,000, or $0.08 per share, for the fourth quarter of 2004. For the fiscal year ended December 31, 2005, the Company reported a net loss of $11,738,000, or $0.18 per share, as compared to a net loss of $15,330,000, or $0.31 per share, for the 2004 fiscal year. The decrease in net loss from 2004 to 2005 was primarily attributable to the one-time receipt of shares in ReNeuron as part of a license and settlement agreement for which the Company recorded approximately $3,736,000 as other income, net of legal and other expenses.
